Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary fructose intolerance.

T M Cox

    Bailliere'S Clinical Gastroenterology
    |March 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Hereditary fructose intolerance (HFI) is an inherited metabolic disorder caused by aldolase B deficiency. A strict diet can cure HFI, allowing affected individuals to live long, healthy lives.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immune signatures underlying post-acute COVID-19 lung sequelae.

    Science immunology·2021
    Same author

    Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.

    Blood cells, molecules & diseases·2017
    Same author

    Orphan drugs: expensive yet necessary.

    QJM : monthly journal of the Association of Physicians·2015
    Same author

    Orphan drugs: expensive yet necessary.

    QJM : monthly journal of the Association of Physicians·2014
    Same author

    On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritis.

    Journal of anatomy·2014
    Same author

    Limits on use of health economic assessments for rare diseases.

    QJM : monthly journal of the Association of Physicians·2014
    Same journal

    Index.

    Bailliere's clinical gastroenterology·2020
    Same journal

    Home enteral and parenteral nutrition in children.

    Bailliere's clinical gastroenterology·1999
    Same journal

    Nutritional support in malnourished paediatric patients.

    Bailliere's clinical gastroenterology·1999
    Same journal

    Cholestasis and end-stage liver disease.

    Bailliere's clinical gastroenterology·1999
    Same journal

    Cystic fibrosis: nutritional consequences and management.

    Bailliere's clinical gastroenterology·1999
    Same journal

    Pancreatic diseases (excluding cystic fibrosis).

    Bailliere's clinical gastroenterology·1999
    See all related articles

    Area of Science:

    • Biochemistry
    • Genetics
    • Metabolic Disorders

    Background:

    • Hereditary fructose intolerance (HFI) is an autosomal recessive metabolic disorder.
    • It results from a deficiency in the enzyme aldolase B, crucial for carbohydrate metabolism.
    • HFI manifests with severe symptoms like abdominal distress and hypoglycemia upon ingesting fructose, sucrose, or sorbitol.

    Purpose of the Study:

    • To investigate the genetic basis and population genetics of hereditary fructose intolerance.
    • To explore the clinical benefits of understanding the molecular basis of inherited diseases.
    • To establish methods for detecting carriers and diagnosing HFI in families.

    Main Methods:

    • Analysis of genetic lesions causing HFI.
    • Population genetic studies to estimate HFI prevalence and carrier frequency.

    Related Experiment Videos

  • Molecular biology investigations of the human aldolase B gene and its mutations.

    • Main Results:

    • Studies suggest HFI affects approximately 1 in 20,000 live births in Switzerland, with carrier frequencies over 1%.
    • Many patients develop food aversions, aiding survival into adulthood.
    • Identification of genetic lesions enables carrier detection and family diagnosis via DNA analysis.

    Conclusions:

    • HFI is a treatable genetic disorder, with strict dietary management leading to a healthy life.
    • Understanding the molecular basis of HFI offers significant clinical benefits, including carrier screening and diagnosis.
    • The study of aldolase B mutations provides insights into enzyme function and molecular biology.